Population-based study of long-term survival in patients with clinically localised prostate cancer

Parker, 1997, Cancer statistics, CA Cancer J Clin, 47, 5, 10.3322/canjclin.47.1.5 Scardino, 1994, Problem of prostate cancer, J Urol, 152, 1677, 10.1016/S0022-5347(17)32357-1 Wasson, 1993, A structured literature review of treatment for localized prostate cancer, Arch Family Med, 2, 487, 10.1001/archfami.2.5.487 Wilt, 1994, The prostate cancer intervention versus observation trial: a randomized trial comparing radical prostatectomy versus expectant management for the treatment of clinically localized prostate cancer, J Urol, 152, 1910, 10.1016/S0022-5347(17)32413-8 Norlén, 1994, Swedish randomized trial of radical prostatectomy versus watchful waiting, Can J Oncol, 4, 38 Austenfeld, 1994, Meta-analysis of the literature: guideline development for prostate cancer treatment, J Urol, 152, 1866, 10.1016/S0022-5347(17)32403-5 Middleton, 1995, Prostate cancer clinical guidelines panel summary report on the management of clinically localized prostate cancer, J Urol, 154, 2144, 10.1016/S0022-5347(01)66718-1 Walsh, 1994, Cancer control and quality of life following anatomical radical retropubic prostatectomy: results at 10 years, J Urol, 152, 1831, 10.1016/S0022-5347(17)32396-0 Zinche, 1994, Long-term (15 years) results after radical prostatectomy for clinically localized (stage T2c or lower) prostate cancer, J Urol, 152, 1850, 10.1016/S0022-5347(17)32399-6 Zietman, 1995, The treatment of prostate cancer by conventional radiation therapy: an analysis of long-term outcome, Int J Radiat Oncol Biol Phys, 32, 287, 10.1016/0360-3016(95)00123-G Bagshaw, 1994, Control of prostate cancer with radiotherapy: long-term results, J Urol, 152, 1781, 10.1016/S0022-5347(17)32385-6 Barry, 1995, Should Medicare provide reimbursement for prostate-specific antigen testing for early detection of prostate cancer?, Urology, 46, 2, 10.1016/S0090-4295(99)80151-4 Narayan, 1995, The role of transrectal ultrasound-guided biopsy-based staging, preoperative serum prostate-specific antigen, and biopsy Gleason score in prediction of final pathologic diagnosis in prostate cancer, Urology, 46, 205, 10.1016/S0090-4295(99)80195-2 1995 Gleason, 1974, Prediction of prognosis for prostatic adenocarcinoma by combined histological grading and clinical staging, J Urol, 11, 58, 10.1016/S0022-5347(17)59889-4 Zincke, 1994, Radical prostatectomy for clinically localized prostate cancer: long-term results of 1,143 patients from a single institution, J Clin Oncol, 12, 2254, 10.1200/JCO.1994.12.11.2254 Johansson, 1992, High 10-year survival rate in patients with early, untreated prostatic cancer, JAMA, 267, 2191, 10.1001/jama.1992.03480160049033 Chodak, 1994, Results of conservative management of clinically localized prostate cancer, N Engl J Med, 330, 242, 10.1056/NEJM199401273300403 Fleming, 1993, Prostate PORT: a decision analysis of alternative treatment for clinically localized prostate cancer, JAMA, 269, 2650, 10.1001/jama.1993.03500200064035 Beck, 1994, A critique of the decision analysis for clinically localized prostate cancer, J Urol, 152, 1894, 10.1016/S0022-5347(17)32409-6 Gerber, 1996, Results of radical prostatectomy in men with clinically localized prostate cancer-multi-institutional pooled analysis, JAMA, 276, 615, 10.1001/jama.1996.03540080037026 Potosky, 1993, Potential for cancer related health services research using a linked Medicare-tumor registry database, Med Care, 31, 732, 10.1097/00005650-199308000-00006 Horm, 1984 Percy, 1981, Accuracy of cancer death certificates and its effect on cancer mortality statistics, Am J Public Health, 71, 242, 10.2105/AJPH.71.3.242 Shambaugh, 1986 1992 Bell, 1992 Middleton, 1996, The management of clinically localized prostate cancer: guidelines from the American Urological Association, CA Cancer J Clin, 46, 249, 10.3322/canjclin.46.4.249 Albertsen, 1996, The impact of comorbidity on life expectancy among men with localized prostate cancer, J Urol, 156, 127, 10.1016/S0022-5347(01)65964-0 Albertsen, 1995, Long-term survival among men with conservatively treated localized prostate cancer, JAMA, 274, 626, 10.1001/jama.1995.03530080042039